For patients at high cardiovascular risk with obesity, semaglutide is associated with reduced burden of total hospital admissions.

For patients with hypertension, initiating treatment with an ARB is associated with the best long-term class persistence.

Accelerated linear growth and weight gain from birth to 4 years of age are associated with earlier pubertal onset, particularly in girls.

The FDA has approved Wegovy (semaglutide) tablets, the first oral GLP-1 receptor agonist for the treatment of obesity.

Credit: Getty Images A reproductive endocrinologist was sued for medical malpractice after a patient received a diagnosis of ovarian cancer after undergoing fertility treatment. In this case, a jury ...

Credit: Getty Images With the FDA approval of Zepbound (tirzepatide) for obstructive sleep apnea, GLP-1 receptor agonists harbor potential beyond weight and diabetes management. In recent years, ...

Credit: Getty Images The American College of Lifestyle Medicine and others released a scientific advisory on nutritional and lifestyle priorities for patients using GLP-1RAs for weight management.

Diabetes monitoring and healthcare. Close up top down view of glucose meter, insulin pen, drug pills and syringe on blue background with copy space in the middle Our drug-drug interaction overview ...

Credit: Getty Images We spoke with endocrinologists to explore the potential of artificial intelligence in the management of chronic disease, including diabetes, obesity, and PCOS. Artificial ...

Credit: Getty Images Stem cell therapies are emerging as potential treatments across the endocrinology realm, from diabetes to autoimmune thyroid disease to osteoporosis. Stem cells are becoming more ...

Credit: Getty Images Glucagon-like peptide-1 receptor agonists (GLP-1 agonists) are a newer class of medications that are FDA-approved to manage type 2 diabetes and obesity in conjunction with diet ...

Type 2 diabetes mellitus is a metabolic disorder characterized by dysregulation of blood glucose caused by relative insulin deficiency and insulin resistance. It is a progressive condition that have ...